References
- KHAN MAB., HASHIM MJ., KING JK., GOVENDER RD., MUSTAFA HM., KAABI JA. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. Journal of Epidemiology and Global Health. 2020;10(1):107–111.
- PAPATHEODOROU K., BANACH M., BEKIARI E., RIZZO M., EDMONS M. Complications of diabetes 2017. Journal of Diabetes Research. Volume 2018. Article ID 3086167.
- SHI GJ., SHI GR., ZHOU JY., ZHANG WJ., GAO CY., JIANG YP., et al. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomedicine & Pharmacotheraphy. 2018;101:510–527.
- MAJUMDER S., ADVANI A. VEGF and the diabetic kidney: more than too much a good thing. Journal of Diabetes and Its Complications. 2017;31:273–279.
- HOFER KB. Vascular endothelial growth factor, from basic research to clinical applications. Int J Mol Sci. 2018. 19. 3750.
- SUN X., ZHANG H., LIU J. WANG G. Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus. Journal of International Medical Research. 2019;47(11):5584–5592.
- TAHERGORABI Z., KHAZAEI M. Imbalance of angiogenesis in diabetic complications: the mechanism. Int J Prev Med. 2012;3:827–38.
- MAHDY RA., NADA WM., HADHOUD KM., EL-TARHONY SA. The role of vascular endothelial growth factor in the progression of diabetic vascular complications. Eye. 2010;24:1576–1584.
- AHUJA S., SAXENA S., AKDUMAN L., MEYER CH., KRUZLIAK P., KHANNA VK. Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy. Int J Retin Vitr. 2019.5:25.
- AMERICAN DIABETES ASSOCIATION. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–SC28.
- CHENG R., MA JX. Angiogenesis in diabetes and obesity. Rev Endocr Metab Disord. 2015;16(1):67–75.
- SUNG HK., DOH KO., SON JE., PARK JG., BAE Y., CHOI S., et al. Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metabolism. 2013;17:61–72.
- LOEBIG M., KLEMENT J., SCHMOLLER A., BETZ S., HEUCK N., SCHWEIGER U., et al. Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS ONE. 2010;5(9):e12610.
- ZHANG Q., FANG W., MA L., WANG ZD., YANG YM., LU YQ. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes. Medicine. 2018;97:15(e0415).
- RUSDIANA R., WIDJAYA SS., AMELIA R., SYARIFAH S., RUSMALAWATI R. The role vascular endothelial growth factor, control glycemic, lipid profile, and hypoxiainducible factor-1alpha at type 2 diabetic patients in North Sumatera, Indonesia. Open Access Maced J Med Sci. 2021;9(B):1215–1218.
- TUFRO A., VERON D. VEGF and podocytes in diabetic nephropathy. Semin Nephrol. 2012;32(4):385–393.
- ZORENA K., MYSLIWSKA J., MYSLIWIEC M. KAPTURSKA KR., MALINOWSKA E., WISNIEWSKI P., et al. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. Journal of Human Hypertension. 2010;24:755–762.
- JIA G., SOWERS JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78:1197–1205.
- MONDAL LK., PRAMANIK S., CHOWDHURY S., BOSE C., BERA D., SAHA A., et al. Do different lipid components accelerate the pathogenesis and severity of diabetic retinopathy.? International Journal of Retina and Vitreous. 2022;8:39.
- ZHANG X., QIU B., WANG Q., SIVAPRASAD S., WANG Y., ZHAO L., et al. Dysregulated serum lipid metabolism promotes the occurrence and development of diabetic retinopathy associated with upregulated circulating levels of VEGF-A, VEGF-D, and PIGF. Front. Med. 2021.8:779413.